Strumento inattivo

Altre lingue Biostage Inc Nasdaq

Azioni

US41690A1060

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

13/05	Harvard Apparatus Regenerative Technology Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
28/03	Harvard Apparatus Regenerative Technology Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Transcript : Harvard Apparatus Regenerative Technology Inc., Q3 2023 Earnings Call, Nov 13, 2023	13/11
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Transcript : Harvard Apparatus Regenerative Technology Inc., Q2 2023 Earnings Call, Aug 14, 2023	14/08/23
Biostage, Inc. Activated Mayo Clinic as the First Site for Clinical Trial in Severe Esophageal Disease	18/07/23
Transcript : Biostage, Inc. - Special Call	20/06/23
Biostage, Inc. Initiates Study Start-Up Activities for Clinical Trial in Severe Esophageal Disease	31/05/23
Biostage Initiates Study Start-Up Activities for Clinical Trial in Severe Esophageal Disease	31/05/23
Biostage, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Biostage, Inc. Appoints Ron Packard to Board of Directors	10/04/23
Biostage, Inc. Auditor Raises 'Going Concern' Doubt	30/03/23
Biostage, Inc Announces Board Changes	02/03/23
Biostage, Inc Announces Executive Changes	02/03/23
Biostage, Inc. Amends CEO Employment Agreement	12/01/23
Biostage, Inc. Announces New Publication Demonstrates Rapid Esophageal Regeneration Using the Biostage Esophageal Implant	23/12/22
Insider Sell: Biostage	09/12/22
Transcript : Biostage, Inc., Q3 2022 Earnings Call, Nov 15, 2022	15/11/22
Biostage, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Biostage Inc Nasdaq

Azioni

US41690A1060

Altre lingue

Filtri